Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

The rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 (Omicron) variant and its resistance to neutralization by vaccinee and convalescent sera are driving a search for monoclonal antibodies with potent neutralization. To provide insight into effective neutral...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Tongqing, Wang, Lingshu, Misasi, John, Pegu, Amarendra, Zhang, Yi, Harris, Darcy R., Olia, Adam S., Talana, Chloe Adrienna, Yang, Eun Sung, Chen, Man, Choe, Misook, Shi, Wei, Teng, I-Ting, Creanga, Adrian, Jenkins, Claudia, Leung, Kwanyee, Liu, Tracy, Stancofski, Erik-Stephane D., Stephens, Tyler, Zhang, Baoshan, Tsybovsky, Yaroslav, Graham, Barney S., Mascola, John R., Sullivan, Nancy J., Kwong, Peter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580340/
https://www.ncbi.nlm.nih.gov/pubmed/35324257
http://dx.doi.org/10.1126/science.abn8897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580340/
https://www.ncbi.nlm.nih.gov/pubmed/35324257
http://dx.doi.org/10.1126/science.abn8897

Ejemplares similares